Conceptio › Archive › ARPHA OAI-PMH Endpoint
ARPHA OAI-PMH Endpoint metadata only CC BY 4.0

Technological approaches to tamoxifen nanoformulation: emphasis on modified chitosan-based nanoparticles: a review

Argilashki,Daniel
ARPHA OAI-PMH Endpoint · Papers · License: CC BY 4.0
Open Source ↗
drug-delivery
Tamoxifen remains a cornerstone in the treatment of estrogen receptor-positive breast cancer, yet its clinical performance is limited by poor aqueous solubility, high lipophilicity, and interindividual variability associated with CYP2D6-mediated formation of its more potent active metabolites. These
Conceptio Open Archive

Analyze & explore related research in Conceptio

Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.

This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 1160469
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive